Promoter holding
64.27%
FP
Fibro Plastichem (India) Pvt Ltd - Due diligence report
A 360° intelligence report on Fibro Plastichem (India) Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth an…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Fibro Plastichem (India) Pvt Ltd — 360° Intelligence Report
Generated from MCA filings & public records88/100
Trust Score
Low Risk
Fibro Plastichem (India) Pvt Ltd is assessed as Low Risk with a Trust Score of 88/100. Fibro Plastichem (India) Pvt Ltd is an active private limited indian non-government company incorporated in 1972, operating in the Manufacturing sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Fibro Plastichem (India) Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 60/100 Moderate
- Open charges exceed net worth - secured lenders rank ahead.
- Profitable - internal accruals available.
- Externally credit-rated (BB+).
Charges position: 6 open (49.21 cr) · 7 satisfied (49.20 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 5 | 48.0 cr |
| State Bank Of India | 1 | 48.0 cr |
| United Bank Of India | 3 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
| Technology Information Forecasting And Assessment | 1 | 48.0 cr |
| Others | 2 | 48.0 cr |
Compliance Score: 81/100 Low Risk
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 1 court forum(s).
- 4 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| MAINAK DATTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUMIT DATTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Suman Raha | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
5 allotment(s) · 6 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Strong Bonds Poly Seal Pvt.ltd. | Subsidiary Company | 74.00% |
Key managerial personnel: SUMIT DATTA (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Profit expanded 1.42 year-on-year.
Asset base grew 2.1x - capacity expansion.
Net margin improved to 24%.
EPFO headcount growing - hiring signal.
Operating for 53+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
6 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence86/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment73/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 6 open charge(s) of 49.21 cr already registered.
- Compliance record supports lending.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events26 Nov 2025
Director ceased
INDRANIL ROYCHOWDHURY
20 Nov 2025
Charge created
Hdfc Bank Limited - 20.53 Lakh
09 Oct 2025
Director appointed
Suman Raha (Additional Director)
24 Mar 2025
Charge created
Hdfc Bank Limited - 17.52 Lakh
21 Mar 2025
Charge created
Hdfc Bank Limited - 6.82 Lakh
10 Dec 2024
Charge satisfied
State Bank Of India
30 Sep 2024
Charge created
Hdfc Bank Limited - 48.32 cr
16 Sep 2024
Last AGM held
Annual general meeting
27 May 2024
Charge created
Hdfc Bank Limited - 27.13 Lakh
31 Mar 2024
Latest balance sheet
Filed with ROC
15 Dec 2023
Charge satisfied
Others
Charge satisfied
United Bank Of India
20 Apr 2023
Charge created
Others - 17.00 Lakh
29 Sep 2020
Charge created
Others - 44.55 Lakh
04 Dec 2019
Charge created
United Bank Of India - 1.85 cr
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
4 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of BB+ from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 5 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Crius | U24232HP2016PTC001137 | Nalagarh, Himachal Pradesh, India |
| Alcon Biosciences | U24230MH1982PTC026953 | Mumbai, Maharashtra, India |
| Bhavin Industries India Private Limited | U24299GJ2020PTC113062 | Ahmedabad, Gujarat, India |
| Calx | U24233MH2012PTC232530 | Jalgaon, Maharashtra, India |
| Alfa Biomed India | U74999PN2016FTC158316 | Pune, Maharashtra, India |
| Biogenetic Drugs Private Limited | U24232RJ2004PTC018909 | Jaipur, Rajasthan, India |
| Westcoast | U24233GJ2007PLC050504 | Ahmedabad, Gujarat, India |
| Palsons Derma Private Limited | U24232WB2008PTC122600 | Kolkata, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Fibro Plastichem (India) Pvt Ltd before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Fibro Plastichem (India) Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Fibro Plastichem (India) Pvt Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Fibro Plastichem (India) Pvt Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Fibro Plastichem (India) Pvt Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Fibro Plastichem (India) Pvt Ltd an active company?
Fibro Plastichem (India) Pvt Ltd has MCA status “Active” with a compliance score of 81/100 (Low Risk).
Is Fibro Plastichem (India) Pvt Ltd financially healthy?
Fibro Plastichem (India) Pvt Ltd has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.
Should I do business with Fibro Plastichem (India) Pvt Ltd?
Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Fibro Plastichem (India) Pvt Ltd?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Fibro Plastichem (India) Pvt Ltd have loans or charges against its assets?
6 open charge(s) are registered against its assets, and 7 earlier charge(s) stand satisfied.
Is Fibro Plastichem (India) Pvt Ltd up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 81/100 (Low Risk).
Is it risky to lend to Fibro Plastichem (India) Pvt Ltd?
Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
